Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Zymergen Inc.
  6. Summary
    ZY   US98985X1000

ZYMERGEN INC.

(ZY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
9.49(c) 9.06(c) 8.54(c) 8.64(c) 7.62(c) Last
2 074 523 1 884 861 1 632 199 2 131 773 2 425 983 Volume
+4.86% -4.53% -5.74% +1.17% -11.81% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 16,5 M - -
Net income 2021 -372 M - -
Net cash position 2021 309 M - -
P/E ratio 2021 -1,66x
Yield 2021 -
Sales 2022 13,7 M - -
Net income 2022 -241 M - -
Net cash position 2022 236 M - -
P/E ratio 2022 -4,26x
Yield 2022 -
Capitalization 780 M 780 M -
EV / Sales 2021 28,6x
EV / Sales 2022 39,8x
Nbr of Employees 758
Free-Float 90,7%
More Financials
Company
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack... 
More about the company
Ratings of Zymergen Inc.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ZYMERGEN INC.
12/03ZYMERGEN ALERT : Bragar Eagel & Squire, P.C. Is Investigating Zymergen Inc. on Behalf of L..
BU
11/22INSIDER BUY : Zymergen
MT
11/15ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/11The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behal..
BU
11/10Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
BU
11/03ZYMERGEN : Q3 Earnings Snapshot
AQ
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
PU
11/03Earnings Flash (ZY) ZYMERGEN Reports Q3 Revenue $4.1M, vs. Street Est of $3.41M
MT
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
AQ
10/26Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021
GL
10/21ZYMERGEN INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or ..
AQ
10/21Zymergen Inc. Announces Stepdown of Jed Dean, Co-Founder, Effective October 31, 2021
CI
10/19Certain Warrants of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-OCT-2..
CI
10/19Certain Stock Options of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-..
CI
10/19Certain Common Stock of Zymergen Inc. are subject to a Lock-Up Agreement Ending on 19-O..
CI
More news
News in other languages on ZYMERGEN INC.
11/22ACHAT D'INITIÉS : Zymergen
11/03Earnings Flash (ZY) ZYMERGEN annonce un chiffre d'affaires de 4,1 millions de dollars p..
10/06Les actions de Zymergen tombent à leur plus bas niveau depuis août dans un contexte de ..
09/23Zymergen supprime 120 emplois dans le cadre d'un programme de restructuration visant à ..
08/05Zymergen nomme un directeur commercial
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 7,62 $
Average target price 9,50 $
Spread / Average Target 24,7%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%780
SHIN-ETSU CHEMICAL CO., LTD.7.12%70 989
BASF SE-8.71%60 548
DUPONT DE NEMOURS, INC.6.15%39 106
ROYAL DSM N.V.35.16%36 632
PIDILITE INDUSTRIES LIMITED25.22%14 933